| Function: | Lowering Blood Pressure |
|---|---|
| Certification: | GMP, ISO, HACCP, KOSHER |
| Type: | Capsule |
| Gender: | Unisex |
| Feature: | Organic, Vitamins, Low-Fat |
| Packaging: | Bottle |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 1.Pharmaceutical GMP Omega 3
2.Content:EPA18%/ DHA12%, 33%/22%...
3.Oblong/oval
4.size:20#,10#,5#
5.Canada quality standard
Product: Omega 3 Softgel Capsule
Description: Clear, light yellow liquid
Size: 20# Oblong (1000mg), 10# Oval/Oblong (500mg), 5#Oval (250mg)
Content: EPA18%/ DHA12%,
EPA33%/ DHA22%,
EPA40%/ DHA20%,
EPA50%/ DHA25%.
Manufacturer: Pharmatech Asia Group
Certificates: Pharmaceutical GMP,
Halal,
ISO,
HACCP
Site Licence issued by Health Canada
Active Ingredient:
EPA (Eicosapentaenoic acid):
The molecular formula: C20H30O2
The molecular weight: 302.451
DHA (Docosahexaenoic acid):
The molecular formula: C22H32O2
The molecular weight: 328.488
Benefits:
Nutritionally important n3 fatty acids include α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), all of which are polyunsaturated.
The most widely available source of EPA and DHA is cold water oily fish such as salmon, herring, mackerel, anchovies and sardines. Oils from these fish have a profile of around seven times as much n3 as n6. Other oily fish such as tuna also contain n3 in somewhat lesser amounts. Consumers of oily fish should be aware of the potential presence of heavy metals and fat-soluble pollutants like PCBs and dioxin which may accumulate up the food chain..
There is strong scientific evidence from human trials that omega-3 fatty acids from fish or fish oil supplements (EPA + DHA) significantly reduce blood triglyceride levels. Benefits appear to be dose-dependent. Fish oil supplements also appear to cause small improvements in high-density lipoprotein ("good cholesterol"); however, increases (worsening) in low-density lipoprotein levels (LDL/"bad cholesterol") are also observed.
Adverse Effects:
Omega-3 fatty acids may increase the risk of bleeding, although there is little evidence of significant bleeding risk at lower doses. Very large intakes of fish oil/omega-3 fatty acids ("Eskimo" amounts) may increase the risk of hemorrhagic (bleeding) stroke. High doses have also been associated with nosebleed and blood in the urine. Fish oils appear to decrease platelet aggregation and prolong bleeding time, increase fibrinolysis (breaking down of blood clots), and may reduce von Willebrand factor.
Skin rashes have been reported rarely.
Pregnancy and Breastfeeding:
It is not known if omega-3 fatty acid supplementation of women during pregnancy or breastfeeding is beneficial to infants. It has been suggested that high intake of omega-3 fatty acids during pregnancy, particularly DHA, may increase birth weight and gestational length (254). However, higher doses may not be advisable due to the potential risk of bleeding. Fatty acids are added to some infant formulas.
Dosage:
The World Health Organization and governmental health agencies of several countries recommend consuming 0.3-0.5 grams of daily EPA + DHA and 0.8-1.1 grams of daily α-linolenic acid. A doctor and pharmacist should be consulted for dosing for other conditions.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}